MGMT and neoplasm: Although the specific covariates varied among studies, commonly adjusted variables comprised age, sex, baseline performance status (e.g., WHO or KPS), extent of resection, tumor grade, molecular markers (e.g., IDH mutation and MGMT promoter methylation status), and treatment modality (Table 1).